Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Norway

Research and Innovation Action · Running

XTREAM Sustainable exploration and biodiscovery of novel products and processes from extreme aquatic microbiomes to expedite the circular bioeconomy

Coordinator
Norce Research AS, Norway
Runs
1 January 2025 to 31 December 2028
Status
Running
EU funding
€5.1m
Total cost
€5.1m
Partners
15 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101182278

What the project is doing

In the project's own words, from its summary on CORDIS.

Microorganisms thriving in extreme environments are a largely untapped reservoir of enzymes, chemicals, and pharmaceutical compounds. Their unique metabolic pathways and regulatory mechanisms enable them to survive under harsh conditions and represent invaluable resources to produce innovative bio-products, offering solutions to address challenges that conventional model organisms cannot. However, extremophile microorganisms remain remarkably underutilized as providers of bio-based solutions.

Sampling extreme environments, screening, identifying and isolating the pertinent microbes is cumbersome, costly and imposes a significant environmental footprint, resulting in low yields, elevated costs, and extended times to market. Developing innovative methodologies is imperative to surmount these barriers in the study of extremophile microbiomes, and to leverage their capabilities for ecological and economic benefits.

XTREAM will unlock the potential of aquatic extremophiles for the discovery of enzymes, drugs, metabolites and chemicals by interdisciplinarily developing innovative tools to facilitate rapid, efficient and sustainable exploration of extreme microbiomes, heralding a new era in the industrial application of extremophiles. The expected results of XTREAM include discovering microbes, enzymes, resistance genes and biosynthetic clusters, with a hybrid workflow of in silico and microfluidics-based discovery, resulting in the commercialization of e.g. ≥200 enzymes for biocatalysis and biorefining, 3 new solutions for antifouling, increasing the revenue of our industrial partners by ca. 10%.

XTREAM assembles 5 leading European SMEs, 4 academic teams and 4 RTOs that have pioneered approaches in functional metagenomics, extremophiles, microfluidics, microbial ecology, and synthetic biology. Diverse XTREAM partners (from synthetic biology to ingredients) at different stages in the research-to-market process provides a unique opportunity for broad value creation.

Topics

Who is involved

OrganisationCityCountryRole
Norce Research ASBergenNorwayCoordinator
Helmholtz-Zentrum Fur Ozeanforschung Kiel (geomar)KielGermanyParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Instituto Nacional De Tecnica Aeroespacial Esteban TerradasTorrejon De Ardoz MadridSpainThird party
Scienseed SLMadridSpainParticipant
Universidad Autonoma De MadridMadridSpainParticipant
Erinn Innovation LimitedDublinIrelandParticipant
Algalif Iceland EhfReykjanesbaerIcelandParticipant
Wageningen UniversityWageningenNetherlandsParticipant
Syngens ASHeimdalNorwayParticipant
Universitetssenteret Pa Svalbard ASLongyearbyenNorwayParticipant
Universidade De AveiroAveiroPortugalParticipant
Pedal Consulting SroMartinSlovakiaParticipant
Prozomix LimitedHaltwhistleUnited KingdomParticipant
Teesside UniversityMiddlesbroughUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI